Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Rotroff

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 20, 2010
Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screeningDaniel M Rotroff, Barbara A Wetmore, David J Dix, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 DiabetesDaniel M Rotroff, Sonja S Pijut, Skylar W Marvel, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Preventing Microglial Reactivity Protects from Acute and Progressive Neuronal Dysfunction, Motor Impairments and Sedation following Alcohol AbuseEvi Paouri, Sarah Stanko, Nadia Gasmi, et al.
JCI Insight|April 4, 2024
Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitisMoyinoluwa Taiwo, Emily Huang, Vai Pathak, et al.
Diabetes|April 14, 2018
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 DiabetesDaniel M Rotroff, Sook Wah Yee, Kaixin Zhou, et al.
Scientific Reports|July 12, 2014
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt T Martin, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Scientific Data|October 18, 2017
Targeted metabolomics and medication classification data from participants in the ADNI1 cohortLisa St John-Williams, Colette Blach, Jon B Toledo, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Clinical Pharmacology and Therapeutics|July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics StudiesCaitrin W McDonough, Helen R Warren, John R Jack, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 20, 2010
Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screeningDaniel M Rotroff, Barbara A Wetmore, David J Dix, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 DiabetesDaniel M Rotroff, Sonja S Pijut, Skylar W Marvel, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Preventing Microglial Reactivity Protects from Acute and Progressive Neuronal Dysfunction, Motor Impairments and Sedation following Alcohol AbuseEvi Paouri, Sarah Stanko, Nadia Gasmi, et al.
JCI Insight|April 4, 2024
Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitisMoyinoluwa Taiwo, Emily Huang, Vai Pathak, et al.
Diabetes|April 14, 2018
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 DiabetesDaniel M Rotroff, Sook Wah Yee, Kaixin Zhou, et al.
Scientific Reports|July 12, 2014
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt T Martin, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Scientific Data|October 18, 2017
Targeted metabolomics and medication classification data from participants in the ADNI1 cohortLisa St John-Williams, Colette Blach, Jon B Toledo, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Clinical Pharmacology and Therapeutics|July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics StudiesCaitrin W McDonough, Helen R Warren, John R Jack, et al.
Pageof 9